5 Best Biotech Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
In this article, we discuss the 5 best biotech stocks to buy according to Mark Lampert.
Olema Pharmaceuticals Inc. (OLMA)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 6,661,503 | $183,591 | 7.16% | |
| 2. | Logos Capital Arsani William | 3,743,875 | $103,181 | 7.44% | |
| 3. | Cormorant Asset Management Bihua Chen | 3,073,485 | $84,705 | 3.44% | |
| 4. | RA Capital Management Peter Kolchinsky | 2,150,404 | $59,265 | 0.82% | |
| 5. | Citadel Investment Group Ken Griffin | 1,477,055 | $40,707 | +3% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $19.00 | 425,000 | Other | 3,270,544 | 2020-11-23 | Filing | |
| $19.00 | 1,160,000 | Director | 1,160,000 | 2020-11-23 | Filing | |
| $19.00 | 74,991 | Large Shareholder, Director | 436,082 | 2020-11-19 | Filing | |
| $19.00 | 446,425 | Large Shareholder, Director | 2,523,265 | 2020-11-19 | Filing | |
| $19.00 | 613,918 | Large Shareholder, Director | 3,392,663 | 2020-11-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $26.88 | 27,668 | 1,790 | 2021-11-10 | Filing | ||
| $28.20 | 4,555 | 1,051,546 | 2021-10-19 | Filing | ||
| $27.85 | 7,445 | 1,056,101 | 2021-10-19 | Filing | ||
| $31.17 | 351 | 52,514 | 2021-10-14 | Filing | ||
| $30.42 | 4,649 | 52,865 | 2021-10-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 2,742,031 | $75,570 | 0% | |
| 2. | 2,475,830 | $68,216 | 0.02% | |
| 3. | 2,339,975 | $64,490 | 0% | |
| 4. | 1,649,204 | $45,451 | 0% | |
| 5. | 1,536,193 | $42,337 | 5.43% |
News See All
5 Pharma Stocks to Buy According to Mark Lampert’s Biotechnology Value Fund
Below is the list of 5 pharma stocks to buy according to Mark Lampert’s Biotechnology Value Fund.
Hedge Fund and Insider Trading News: York Capital Management, Point72 Asset Management, Elliott Advisors, Cresco Labs Inc (CRLBF), Estee Lauder Companies Inc (EL), and More
Blackstart Capital, which listed $319 million under management on a recent disclosure form, has terminated its registration with the Securities and Exchange Commission.
Billionaire Hedge Funds
